Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Lol

<< Previous

Bullboard Posts

Next >>

Comment by themagicboxon Aug 19, 2021 3:31pm

127 Views

Post# 33734372

RE:RE:RE:RE:RE:Lol

Wrong again FUD fairy. Like I said before I am riding the free warrants from the bought deals haha!!

Keep commenting I am sure Pez will make another greatest hits list from comments LOL!

Rarbar99 wrote: Yet another loser who held through the 70% crash. I've checked your history as well and same scenario, you kept calling people fud fairies and tried to make fun of bears.

in the end, the bears were right, and you were a loser. And yet you still have the nerve to call people "fud" LOL.